Product fact sheet
MitoADAPT MAX 4.0: Technical Specifications & Independent Lab Data
Source-backed MitoADAPT MAX 4.0 hardware facts, including eight-wavelength controls and LightLab wall draw, radiant power and six-inch irradiance measurements.
A larger eight-wavelength, mode-selectable MitoADAPT panel with current manufacturer specifications and a completed LightLab report for the tested MAX 4.0 sample.
larger-panel comparisons with completed third-party radiometric measurements, buyers comparing configurable wavelength modes with measured electrical and optical output
anyone treating wavelength count or radiant power as proof of superior clinical outcomes, buyers expecting Homeapotherapy common-protocol hands-on testing
Key tradeoff: The MAX 4.0 has unusually detailed third-party hardware measurements, but those measurements describe a submitted sample and protocol rather than clinical superiority.
This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.
The MitoADAPT MAX 4.0 is the larger individual panel in Mito Red Light’s eight-wavelength, mode-selectable MitoADAPT family. Its current manufacturer page documents the physical/control architecture, while Mito’s independent-test index publishes LightLab International measurements for the tested MAX 4.0 sample.
Manufacturer power and measured power are different fields
The manufacturer lists 460 W power consumption. LightLab measured 456.1 W wall draw for the submitted sample and 142.5 W total radiant power. Those figures describe electrical input and optical output respectively and should not be treated as interchangeable.
What the LightLab report adds
At six inches under the stated Area Below LEDs methodology, the tested MAX 4.0 sample recorded 49.4 mW/cm² average irradiance and 59.3 mW/cm² peak irradiance. The independent-test index identifies report LLIA002765-002, dated 2025-09-12.
Those measurements are useful hardware evidence. They are not Homeapotherapy measurements and do not establish that the device produces better clinical outcomes than another panel.
Current manufacturer-documented hardware
The current comparison table lists a 12 × 36 inch panel-only footprint, 25 lb weight, 288 lenses / 576 chips, and eleven selectable wavelength combinations. Published wavelength peaks are 590, 630, 660, 670, 810, 830, 850, and 940 nm.
What remains unknown
Homeapotherapy has not repeated the LightLab protocol or measured heat, fan noise, spectral uniformity, setup friction, or repeated-unit variation under one cross-brand protocol.
For help interpreting irradiance, radiant power and electrical draw, see How to Read Red Light Device Specifications.
Technical specifications
Published specs and what they mean
Physical
- Panel dimensions
- 12 × 36 in (W × H; panel only) Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Weight
- 25 lb Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
Optical
- Published wavelengths
- 590 / 630 / 660 / 670 / 810 / 830 / 850 / 940 nm Basis: Manufacturer published Current manufacturer specification. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- LED architecture
- 288 lenses / 576 chips Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Measured total radiant power
- 142.5 W Basis: Independent lab Conditions: LightLab International ISO/IEC 17025-accredited measurement; report LLIA002765-002. LightLab report LLIA002765-002. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
- Average irradiance at 6 in
- 49.4 mW/cm² Basis: Independent lab Conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm; report LLIA002765-002. LightLab spatial average for the tested sample. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
- Peak irradiance at 6 in
- 59.3 mW/cm² Basis: Independent lab Conditions: Six inches; 380–1000 nm; report LLIA002765-002. LightLab peak for the tested sample. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
Electrical
- Published power consumption
- 460 W Basis: Manufacturer published Current manufacturer comparison table. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
- Measured wall draw
- 456.1 W Basis: Independent lab Conditions: LightLab International; six-inch device distance; Area Below LEDs geometry; report LLIA002765-002. LightLab report LLIA002765-002; tested 2025-09-12. Source: Independent ISO/IEC 17025 Panel Test Data (HTML data index)
Controls
- Running modes
- 11 selectable wavelength combinations Basis: Manufacturer published Manufacturer describes eleven mode-selectable wavelength combinations. Source: MitoADAPT 4.0 Red Light Therapy Panel Series
What the current record does not establish
- Homeapotherapy has not independently repeated the LightLab protocol.
- The normalized LightLab values describe the tested MAX 4.0 sample under the stated six-inch Area Below LEDs method.
- No clinical ranking is inferred from the eight-wavelength architecture or measured output.
A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.
Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.
Dose and irradiance context
What the output number means over time
Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.
Neutral conversion from the independent average measurement
Normalized measured average: 49.4 mW/cm².
Measurement conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm; report LLIA002765-002.
- 1 minute
- 2.96 J/cm²
- 5 minutes
- 14.82 J/cm²
- 10 minutes
- 29.64 J/cm²
- 20 minutes
- 59.28 J/cm²
These figures are arithmetic translations of one independently measured area-average irradiance. They are not suggested session lengths, target fluences or evidence that the same irradiance reaches tissue at a different distance, body contour, device mode or treatment geometry.
What this calculation still cannot tell you
- whether this is an effective dose for any condition;
- how irradiance changes at a different distance or across curved anatomy;
- how much energy reaches tissue below the surface;
- whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
- whether peak irradiance would produce the same area exposure as the average value shown here.
Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.
Clinical evidence context
Where these wavelengths overlap with human research
Published device wavelengths: 590 / 630 / 660 / 670 / 810 / 830 / 850 / 940 nm.
This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.
Research areas worth checking
- Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
- Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
- Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
- Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
- Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
- Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
- See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.
Do not infer from wavelength overlap
- that this device is clinically proven for the linked condition;
- that more wavelengths are better;
- that the highest published irradiance is the best dose;
- that an open wound should be treated with a consumer device without appropriate wound assessment.
For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.
Safety first
What should make you slow down?
Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.
Where to buy
Current tracked merchants
Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.
No merchant destination is currently tracked for this product.
Source trail
Primary documents and supporting evidence
- MitoADAPT 4.0 Red Light Therapy Panel SeriesMito Red Light · Manufacturer · retrieved 2026-08-11
- Independent ISO/IEC 17025 Panel Test DataMito Red Light / LightLab International · Independent lab · HTML data index · retrieved 2026-08-11
- Product Manuals & VideosMito Red Light · Manufacturer manual · Manual index · retrieved 2026-08-11